These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33445307)

  • 41. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome.
    Varga R; Eriksson M; Erdos MR; Olive M; Harten I; Kolodgie F; Capell BC; Cheng J; Faddah D; Perkins S; Avallone H; San H; Qu X; Ganesh S; Gordon LB; Virmani R; Wight TN; Nabel EG; Collins FS
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3250-5. PubMed ID: 16492728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA.
    Nissan X; Blondel S; Navarro C; Maury Y; Denis C; Girard M; Martinat C; De Sandre-Giovannoli A; Levy N; Peschanski M
    Cell Rep; 2012 Jul; 2(1):1-9. PubMed ID: 22840390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A High Throughput Phenotypic Screening reveals compounds that counteract premature osteogenic differentiation of HGPS iPS-derived mesenchymal stem cells.
    Lo Cicero A; Jaskowiak AL; Egesipe AL; Tournois J; Brinon B; Pitrez PR; Ferreira L; de Sandre-Giovannoli A; Levy N; Nissan X
    Sci Rep; 2016 Oct; 6():34798. PubMed ID: 27739443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
    Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson-Gilford Progeria Syndrome.
    Aguado J; Sola-Carvajal A; Cancila V; Revêchon G; Ong PF; Jones-Weinert CW; Wallén Arzt E; Lattanzi G; Dreesen O; Tripodo C; Rossiello F; Eriksson M; d'Adda di Fagagna F
    Nat Commun; 2019 Nov; 10(1):4990. PubMed ID: 31740672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
    Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
    Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of vascular aging: What can we learn from Hutchinson-Gilford progeria syndrome?
    Del Campo L; Hamczyk MR; Andrés V; Martínez-González J; Rodríguez C;
    Clin Investig Arterioscler; 2018; 30(3):120-132. PubMed ID: 29602596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restoring SIRT6 Expression in Hutchinson-Gilford Progeria Syndrome Cells Impedes Premature Senescence and Formation of Dysmorphic Nuclei.
    Endisha H; Merrill-Schools J; Zhao M; Bristol M; Wang X; Kubben N; Elmore LW
    Pathobiology; 2015; 82(1):9-20. PubMed ID: 25765721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity.
    García-Aguirre I; Alamillo-Iniesta A; Rodríguez-Pérez R; Vélez-Aguilera G; Amaro-Encarnación E; Jiménez-Gutiérrez E; Vásquez-Limeta A; Samuel Laredo-Cisneros M; Morales-Lázaro SL; Tiburcio-Félix R; Ortega A; Magaña JJ; Winder SJ; Cisneros B
    Aging Cell; 2019 Oct; 18(5):e13002. PubMed ID: 31305018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generation and characterization of a novel knockin minipig model of Hutchinson-Gilford progeria syndrome.
    Dorado B; Pløen GG; Barettino A; Macías A; Gonzalo P; Andrés-Manzano MJ; González-Gómez C; Galán-Arriola C; Alfonso JM; Lobo M; López-Martín GJ; Molina A; Sánchez-Sánchez R; Gadea J; Sánchez-González J; Liu Y; Callesen H; Filgueiras-Rama D; Ibáñez B; Sørensen CB; Andrés V
    Cell Discov; 2019; 5():16. PubMed ID: 30911407
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential Benefits of Allogeneic Haploidentical Adipose Tissue-Derived Stromal Vascular Fraction in a Hutchinson-Gilford Progeria Syndrome Patient.
    Pak J; Lee JH; Jeon JH; Kim YB; Jeong BC; Lee SH
    Front Bioeng Biotechnol; 2020; 8():574010. PubMed ID: 33195136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
    Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
    Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longwave UV light induces the aging-associated progerin.
    Takeuchi H; Rünger TM
    J Invest Dermatol; 2013 Jul; 133(7):1857-62. PubMed ID: 23392295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disrupting the LINC complex in smooth muscle cells reduces aortic disease in a mouse model of Hutchinson-Gilford progeria syndrome.
    Kim PH; Luu J; Heizer P; Tu Y; Weston TA; Chen N; Lim C; Li RL; Lin PY; Dunn JCY; Hodzic D; Young SG; Fong LG
    Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microbiome at sites of gingival recession in children with Hutchinson-Gilford progeria syndrome.
    Bassir SH; Chase I; Paster BJ; Gordon LB; Kleinman ME; Kieran MW; Kim DM; Sonis A
    J Periodontol; 2018 Jun; 89(6):635-644. PubMed ID: 29520806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
    Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
    J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hutchinson-Gilford progeria syndrome.
    Ullrich NJ; Gordon LB
    Handb Clin Neurol; 2015; 132():249-64. PubMed ID: 26564085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular disease modeling using induced pluripotent stem cells: Focus in Hutchinson-Gilford Progeria Syndrome.
    Pitrez PR; Rosa SC; Praça C; Ferreira L
    Biochem Biophys Res Commun; 2016 May; 473(3):710-8. PubMed ID: 26474704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HGPS-derived iPSCs for the ages.
    Misteli T
    Cell Stem Cell; 2011 Jan; 8(1):4-6. PubMed ID: 21211775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smooth Muscle Cell Death Drives an Osteochondrogenic Phenotype and Severe Proximal Vascular Disease in Progeria.
    Murtada SI; Kawamura Y; Cavinato C; Wang M; Ramachandra AB; Spronck B; Tellides G; Humphrey JD
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.